These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 27015859)

  • 1. Meldonium use by athletes at the Baku 2015 European Games.
    Stuart M; Schneider C; Steinbach K
    Br J Sports Med; 2016 Jun; 50(11):694-8. PubMed ID: 27015859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meldonium long-term excretion period and pharmacokinetics in blood and urine of healthy athlete volunteers.
    Rabin O; Uiba V; Miroshnikova Y; Zabelin M; Samoylov A; Karkischenko V; Semyonov S; Astrelina T; Razinkin S
    Drug Test Anal; 2019 Apr; 11(4):554-566. PubMed ID: 30328291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Story behind meldonium-from pharmacology to performance enhancement: a narrative review.
    Schobersberger W; Dünnwald T; Gmeiner G; Blank C
    Br J Sports Med; 2017 Jan; 51(1):22-25. PubMed ID: 27465696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mildronate (Meldonium) in professional sports - monitoring doping control urine samples using hydrophilic interaction liquid chromatography - high resolution/high accuracy mass spectrometry.
    Görgens C; Guddat S; Dib J; Geyer H; Schänzer W; Thevis M
    Drug Test Anal; 2015; 7(11-12):973-9. PubMed ID: 25847280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medication use in athletes selected for doping control at the Sydney Olympics (2000).
    Corrigan B; Kazlauskas R
    Clin J Sport Med; 2003 Jan; 13(1):33-40. PubMed ID: 12544162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary excretion studies of meldonium after multidose parenteral application.
    Forsdahl G; Jančić-Stojanović B; Anđelković M; Dikić N; Geisendorfer T; Jeitler V; Gmeiner G
    J Pharm Biomed Anal; 2018 Nov; 161():289-295. PubMed ID: 30189410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doping control from a global and national perspective.
    Fraser AD
    Ther Drug Monit; 2004 Apr; 26(2):171-4. PubMed ID: 15228160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The atypical excretion profile of meldonium: Comparison of urinary detection windows after single- and multiple-dose application in healthy volunteers.
    Görgens C; Guddat S; Bosse C; Geyer H; Pop V; Schänzer W; Thevis M
    J Pharm Biomed Anal; 2017 May; 138():175-179. PubMed ID: 28213178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Medication, athletes and doping regulations].
    Hartgens F
    Ned Tijdschr Geneeskd; 2008 Aug; 152(33):1844-8. PubMed ID: 18783164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unraveling the complexity of anti-doping analysis: reassessing meldonium detection and doping verdicts in a case study.
    Cristoni S; Vitarelli F; Spiti S; Brambilla M; Larini M; Calabrone L; Brogna C; Malvandi AM; Conti M; Puccio G; Donato K; Beccari T; Bertelli M; Leoni V
    Eur Rev Med Pharmacol Sci; 2023 Dec; 27(6 Suppl):114-118. PubMed ID: 38112958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meldonium residues in milk: A possible scenario for inadvertent doping in sports?
    Guddat S; Görgens C; Sobolevsky T; Thevis M
    Drug Test Anal; 2021 Nov; 13(11-12):1906-1910. PubMed ID: 34448364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of meldonium in exercised thoroughbred horses.
    Knych HK; Stanley SD; McKemie DS; Arthur RM; Bondesson U; Hedeland M; Thevis M; Kass PH
    Drug Test Anal; 2017 Sep; 9(9):1392-1399. PubMed ID: 28513092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A forensic perspective of the AFL investigation into peptides: an antidoping investigation case study.
    Harcourt PR; Marclay F; Clothier B
    Br J Sports Med; 2014 May; 48(10):810-3. PubMed ID: 24642697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Athlete Biological Passport: an integral element of innovative strategies in antidoping.
    Vernec AR
    Br J Sports Med; 2014 May; 48(10):817-9. PubMed ID: 24659508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel antidoping and medical care delivery model at the 2nd Summer Youth Olympic Games (2014), Nanjing China.
    Mountjoy M; Akef N; Budgett R; Greinig S; Li G; Manikavasagam J; Soligard T; Haiming X; Yang X
    Br J Sports Med; 2015 Jul; 49(13):887-92. PubMed ID: 25833900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The enigma of inhaled salbutamol and sport: unresolved after 45 years.
    Fitch KD
    Drug Test Anal; 2017 Jul; 9(7):977-982. PubMed ID: 28294577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating the use of stimulants in out-of-competition sport samples.
    Boghosian T; Mazzoni I; Barroso O; Rabin O
    J Anal Toxicol; 2011 Nov; 35(9):613-6. PubMed ID: 22080900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Narrowing the gap between the number of athletes who dope and the number of athletes who are caught: scientific advances that increase the efficacy of antidoping tests.
    Botrè F; de la Torre X; Donati F; Mazzarino M
    Br J Sports Med; 2014 May; 48(10):833-6. PubMed ID: 24668049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacy services at the PyeongChang 2018 Olympic and Paralympic Winter Games.
    Stuart M; Kwon YI; Rhie SJ
    Br J Sports Med; 2019 Sep; 53(17):1105-1110. PubMed ID: 30894336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-intentional doping in sports.
    Yonamine M; Garcia PR; de Moraes Moreau RL
    Sports Med; 2004; 34(11):697-704. PubMed ID: 15456345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.